Penumbra (PEN) Invested Capital (2019 - 2025)
Penumbra's (PEN) quarterly Invested Capital came in at $23.1 million in Q4 2025, down 4.12% year-on-year from $24.1 million in Q4 2024, and down 4.12% on a QoQ basis from $24.1 million in Q4 2024.
Penumbra (PEN) Invested Capital (2019 - 2025) Analysis & Trends
Penumbra (PEN) has 7 years of Invested Capital data on file, last reported at $23.1 million in Q4 2025.
- On a quarterly basis, Invested Capital fell 4.12% year-over-year to $23.1 million in Q4 2025; TTM through Mar 2026 was $23.1 million, a 4.12% decrease from a year earlier, with the FY2025 full-year figure at $23.1 million, down 4.12% from the prior year.
- Invested Capital for Q4 2025 stood at $23.1 million, down from $24.1 million in the prior quarter.
- Over the last five years, Invested Capital for PEN reached as high as $28.4 million in Q3 2021 and fell as low as $23.1 million in Q4 2025.
- Historically, Invested Capital has averaged $26.6 million across 5 years, with a median of $27.2 million in 2022.
- Across the five-year window, Invested Capital fell 0.57% in 2021 and decreased 6.99% in 2024, its largest moves.
- Year by year, Invested Capital stood at $28.2 million in 2021, then declined by 5.14% to $26.8 million in 2022, then slipped by 3.26% to $25.9 million in 2023, then dropped by 6.99% to $24.1 million in 2024, then decreased by 4.12% to $23.1 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $23.1 million in Q4 2025, $24.1 million in Q4 2024, and $25.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.11 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Dec 31, 2023 | 25.91 Mn |
| Dec 31, 2022 | 26.79 Mn |
| Sep 30, 2022 | 27.20 Mn |
| Jun 30, 2022 | 27.46 Mn |
| Mar 31, 2022 | 27.89 Mn |
| Dec 31, 2021 | 28.24 Mn |
| Sep 30, 2021 | 28.40 Mn |
| Dec 31, 2020 | 28.40 Mn |
| Jun 30, 2020 | 27.22 Mn |
| Mar 31, 2020 | 28.94 Mn |
| Dec 31, 2019 | 30.91 Mn |